Officially, China's vaccination rate is above 90%, but the rate for...
Category:
Facts
Latest
WHO releases updated guidelines on treatment of drug-resistant tuberculosis
''Building on the newly available data, we now have a better and...
Meta takes down CyberRoot Risk Advisory’s 40 accounts, 900 Chinese a/cs
''We removed a network of more than 40 accounts on Facebook and...
Amid raging second COVID-19 wave, the elderly battle loneliness and anxiety
The COVID-19 pandemic has been particularly difficult for people like Sarin who have been living independently and are elderly. Besides being highly susceptible to the virus, their old age has also made it difficult for them to commute and socialise, adding to their loneliness and anxiety.
Remdesivir not magic bullet, does not reduce mortality, says AIIMS chief
“In major studies, remdesivir was shown to be useful only in those hospitalised patients with falling oxygen saturation and having infiltrates on chest X-ray or CT-scan. It was of no use if given early in mild and asymptomatic patients and also if administered too late,” Dr Guleria said.
Apple explains environmental benefit behind eliminating chargers from iPhone, Apple Watch
While citing the reason over the removal of power adapters from boxes, the company explained, “Since removing them from iPhone and Apple Watch packaging last year, we’ve avoided mining a significant amount of materials from the earth, and we’ve eliminated the emissions that come from processing and transporting them.” The American company also mentioned that leaving out power adapters was a bold change and a necessary one for the planet.
Need of 3rd booster dose based more upon conjecture than data: Experts
Pfizer and Moderna recently announced that people who have received both doses of the Pfizer-BioNTech or Moderna coronavirus vaccines will probably need a booster shot this year and might need an annual shot thereafter.
Earlier this month, an expert panel of the Drugs Controller General of India (DCGI)had permitted Bharat Biotech to give a third dose of its COVID-19 vaccine Covaxin to a few volunteers in its clinical trials.
Young Covid survivors not safe from reinfection: Lancet
“Immunity is not guaranteed by past infection, and vaccinations that provide additional protection are still needed for those who have had Covid-19,” said Professor Stuart Sealfon, from the Icahn School of Medicine at Mount Sinai, the US.
India has a double mutant Coronavirus variant. Should we be worried?
The new variant, which has a so-called double mutation, is thought to be fueling India’s deadlier new wave of infections that has made it the world’s second worst-hit country, surpassing Brazil, and has already begun to overwhelm its hospitals and crematoriums. The Asian nation has reported more than 14 million Covid cases so far and more than 174,300 fatalities.
Study reveals unhealthy lifestyle only explains small part of health inequity in UK, US adults
It is well known that disadvantaged socioeconomic status (the measure of a person’s social and economic standing) and unhealthy lifestyles are linked to poor health.
EU throws weight behind Pfizer-BioNTech and new technology
“We need to focus on technologies that have proven their worth,” said EU Commission President Ursula von der Leyen.
3rd vax dose likely needed within 12 months: Pfizer CEO
“A likely scenario is that there will be likely a need for a third dose, somewhere between six and 12 months and then from there, there will be an annual re-vaccination, but all of that needs to be confirmed. And again, the variants will play a key role,” Pfizer Chief Executive Officer Albert Bourla said.
Rare blood clotting risk more for Covid-19 than for vaccines: Oxford study
“There are concerns about possible associations between vaccines, and cerebral venous thrombosis (CVT), causing governments and regulators to restrict the use of certain vaccines,” said Paul Harrison, Head of the Translational Neurobiology Group at the University of Oxford.
“Yet, one key question remained unknown: What is the risk of CVT following a diagnosis of Covid-19?” Harrison said.